Clinical outcome and costs of nosocomial and community-acquired Staphylococcus aureus bloodstream infection in haemodialysis patients

This publication has 27 references indexed in Scilit:

• Costs and Outcomes Among Hemodialysis-Dependent Patients With Methicillin-Resistant or Methicillin-SusceptibleStaphylococcus aureusBacteremia
  Infection Control & Hospital Epidemiology, 2005
• Risk Factors and Costs Associated With Methicillin-Resistant Staphylococcus aureus Bloodstream Infections
  Infection Control & Hospital Epidemiology, 2004
• American Society of Diagnostic and Interventional Nephrology: Section Editor: Stephen Ash: Catheter Management Protocol for Catheter‐Related Bacteremia Prophylaxis
  Seminars in Dialysis, 2003
• A Prospective Multicenter Study of Staphylococcus aureus Bacteremia
  Medicine, 2003
• Use of aStaphylococcus aureusConjugate Vaccine in Patients Receiving Hemodialysis
  New England Journal of Medicine, 2002
• Vascular access use in Europe and the United States: Results from the DOPPS
  Kidney International, 2002
• The Economic Impact of Methicillin-Resistant Staphylococcus aureus in Canadian Hospitals
  Infection Control & Hospital Epidemiology, 2001
• Methicillin-ResistantStaphylococcus aureusin the Community: A Hospital-Based Study
  Infection Control & Hospital Epidemiology, 1999
• Nosocomial infections in medical intensive care units in the United States
  Critical Care Medicine, 1999
• Vascular access for hemodialysis
  Kidney International, 1999